Navigation Links
Tamaris Announces Foot and Leg Ulcers Pose Significant Health Threat
Date:1/27/2009

A new research study could redefine treatment for disease

Chicago, IL (Vocus) January 27, 2009 -- Americans are living longer, but living longer means our aging population is at greater risk for acquiring disease. For those with high cholesterol, diabetes and high blood pressure, Peripheral Artery Disease (PAD) is of particular concern.

PAD, often described as "poor circulation," is diagnosed when the large arteries of the leg narrow thereby restricting blood flow. The tissues then become starved of the blood, nutrients, and oxygen they need, and in its most advanced form, skin ulcers begin to develop. At this stage of PAD, called Critical Limb Ischemia (CLI), the health threat is serious.

The threat is so serious that it is difficult to grasp, but here are the facts: PAD at the stage of Critical Limb Ischemia presents the likelihood of amputation or even death. At this time, there are no prescription drugs available to effectively treat Critical Limb Ischemia, and there are limited treatments available that will delay or prevent amputation.

While these facts present a grim outlook, there is hope, thanks to a unique new opportunity. Robert Jeffrey, MD is currently conducting an investigational research study for PAD at the stage of Critical Limb Ischemia with foot and/or leg ulcers. It is anticipated that the investigational study medication may promote new blood vessel growth, and may delay the time to amputation and/or death.

The research study is currently seeking qualified participants. Individuals must be: 50 years of age or older with stable skin ulcers or non-infected gangrene on a foot or leg; diagnosed with Peripheral Arterial Disease (PAD) at the stage of Critical Limb Ischemia; and be unsuitable for by-pass or revascularization. Additional criteria also apply.

If you or someone you know suffers with skin ulcers due to PAD at the stage of Critical Limb Ischemia, please call us to determine eligibility at 1-888-853-4656 ... or visit our web site at www.tamarisstudy.com.

This research study is now underway throughout the United States, including the Chicago area.

Today's research touches our future ... and there is a possibility that the information obtained in this study may help in the future development of a new therapy for those who suffer from Critical Limb Ischemia with foot and/or leg ulcers. For more information, please contact Hal Coxon at (847) 919-1005 or via email at halcoxon(at)axmarketing.com.

Contact:
Hal Coxon
Axiom Accelerated Clinical Patient Recruitment
(847) 919-1005
halcoxon(at)axmarketing.com
www.tamarisstudy.com.

###

Read the full story at http://www.prweb.com/releases/Peripheral_Artery_Disease/Critical_Limb_Ischemia/prweb1903004.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Early this week, Team Iconic at ... of Nestlé KITKAT as the first global confectionery brand sourced from 100% sustainable cocoa. ... the quality of their product, through activities that focus on better farming, better lives ...
(Date:2/10/2016)... ... February 10, 2016 , ... As part of its ongoing series of ... Each webinar features a dynamic expert and thoughtful presentation to give attendees a ... facilities. Both events are free to attend, but registration is required. ...
(Date:2/10/2016)... ... February 10, 2016 , ... Emergency rooms provide emergency care to ... this can leave patients with dental emergencies at risk of losing a tooth or ... dental care. , Common dental emergencies include:, , Avulsed ...
(Date:2/10/2016)... ... 10, 2016 , ... Intalere’s 2016 Executive Forum, taking place ... the country’s top healthcare executives to share insights on transformational strategies to drive ... is the provider-centric perspective, experience, expertise and strategy shared by the participants,” said ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... Emmy award winner and inspirational speaker Jan Fox will serve as keynote speaker ... Boldly will provide participants with tools to more effectively communicate with their own ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... OR AKIVA, Israel , February 10, ... Ltd., a leader in the field of cartilage repair, ... on February 5, 2016. The $15 million investment was ... leading Chinese pharmaceutical manufacturer, and was joined by existing ... Financial Holdings and both the Technion Research & Development ...
(Date:2/10/2016)... New York , February 10, 2016 ... Growth, Trends and Forecast 2015 - 2023 ", reveals that ... rather slow growth from 2015 to 2023 owing to patent ... a meager CAGR of 1.30% during the forecast period, the ... to US$38.9 bn in 2023. --> Antibacterial Drugs ...
(Date:2/10/2016)... 2016  Silicon Biosystems Menarini Inc., a developer ... uncover the biological complexities of disease at the ... of innovative technologies for genomics research, today announced ... enabling translational researchers to obtain high-quality sequencing results ... and normal cells in an optimized and seamless ...
Breaking Medicine Technology: